SLC5A2 and nonpapillary renal cell carcinoma: We addressed these limitations in our study by evaluating the impact of SGLT2 on the progression of a VHL mutant ccRCC cell line in which the mutation had resulted in metabolic reprogramming of glucose metabolism.